Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001398344-25-007139
Filing Date
2025-04-15
Accepted
2025-04-15 12:22:43
Documents
1
Period of Report
2025-02-25

Document Format Files

Seq Description Document Type Size
1 fp0093058-3_4.html 4  
1 fp0093058-3_4.xml 4 14611
  Complete submission text file 0001398344-25-007139.txt   17838
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010
Business Address
FAKHRY JAD (Reporting) CIK: 0001588217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 25838453

Mailing Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010
Business Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010 650-239-9049
POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) CIK: 0001588273 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 25838455

Mailing Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010
Business Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010 650-239-9049
POPLAR POINT CAPITAL GP LLC (Reporting) CIK: 0001588288 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 25838454

Mailing Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010
Business Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010 650-239-9049
POPLAR POINT CAPITAL PARTNERS LP (Reporting) CIK: 0001588289 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 25838456